These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 7371593)

  • 1. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
    Carlson RA; Gorski J
    Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen receptor in human endometrium--energy requirement, stability and subunit structure-- (author's transl)].
    Ozaki M; Kurachi K
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):774-83. PubMed ID: 1035170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone action in hamster uterus: rapid inhibition of 3H-estradiol retention by the nuclear fraction.
    Evans RW; Leavitt WW
    Endocrinology; 1980 Oct; 107(4):1261-3. PubMed ID: 7408773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol-17beta receptors in the immature rat ovary.
    Saiduddin S; Zassenhaus HP
    Steroids; 1977 Feb; 29(2):197-213. PubMed ID: 841622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rat alpha-fetoprotein administration on estradiol free fraction, the onset of puberty, and neural and uterine nuclear estrogen receptors.
    Greenstein BD
    Endocrinology; 1992 Jun; 130(6):3184-90. PubMed ID: 1375894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF; Singh RK; Mak P; Callard GV
    Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of estrogen receptors in granulosa cells of immature rats.
    Tonetta SA; Ireland JJ
    Steroids; 1983 Oct; 42(4):427-40. PubMed ID: 6679947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
    Metzger DA; Curtis S; Korach KS
    Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.